Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Marchetti

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Current Aging Science|July 31, 2013
Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestorationFrancesca L 'Episcopo, Cataldo Tirolo, Nuccio Testa, et al.
CNS & Neurological Disorders Drug Targets|May 5, 2010
Glia as a turning point in the therapeutic strategy of Parkinson's diseaseFrancesca L' Episcopo, Cataldo Tirolo, Nuccio Testa, et al.
Frontiers in Aging Neuroscience|April 24, 2025
Corrigendum: Boosting antioxidant self-defenses by grafting astrocytes rejuvenates the aged microenvironment and mitigates nigrostriatal toxicity in parkinsonian brain via an Nrf2-driven Wnt/β-catenin prosurvival axisMaria Francesca Serapide, Francesca L'Episcopo, Cataldo Tirolo, et al.
Frontiers in Aging Neuroscience|April 1, 2020
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain <i>via</i> an <i>Nrf2-Driven Wnt/β-Catenin</i> Prosurvival AxisMaria Francesca Serapide, Francesca L'Episcopo, Cataldo Tirolo, et al.
Rejuvenation Research|July 29, 2011
Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged miceFrancesca L'episcopo, Cataldo Tirolo, Nunzio Testa, et al.
Aging and Disease|September 16, 2021
Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson's DiseaseLoredana Leggio, Greta Paternò, Silvia Vivarelli, et al.
International Journal of Molecular Sciences|December 14, 2017
microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic ApproachesLoredana Leggio, Silvia Vivarelli, Francesca L'Episcopo, et al.
Journal of Pineal Research|February 28, 2006
Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's diseaseGaia Rocchitta, Rossana Migheli, Giovanni Esposito, et al.
Advanced Healthcare Materials|September 1, 2020
Mastering the Tools: Natural versus Artificial Vesicles in NanomedicineLoredana Leggio, Giuseppe Arrabito, Vittorio Ferrara, et al.
Annals of the New York Academy of Sciences|January 22, 2005
Apoptotic cell death and amyloid precursor protein signaling in neuroblastoma SH-SY5Y cellsValentina Venezia, Claudio Russo, Emanuela Repetto, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Current Aging Science|July 31, 2013
Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestorationFrancesca L 'Episcopo, Cataldo Tirolo, Nuccio Testa, et al.
CNS & Neurological Disorders Drug Targets|May 5, 2010
Glia as a turning point in the therapeutic strategy of Parkinson's diseaseFrancesca L' Episcopo, Cataldo Tirolo, Nuccio Testa, et al.
Frontiers in Aging Neuroscience|April 24, 2025
Corrigendum: Boosting antioxidant self-defenses by grafting astrocytes rejuvenates the aged microenvironment and mitigates nigrostriatal toxicity in parkinsonian brain via an Nrf2-driven Wnt/β-catenin prosurvival axisMaria Francesca Serapide, Francesca L'Episcopo, Cataldo Tirolo, et al.
Frontiers in Aging Neuroscience|April 1, 2020
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain <i>via</i> an <i>Nrf2-Driven Wnt/β-Catenin</i> Prosurvival AxisMaria Francesca Serapide, Francesca L'Episcopo, Cataldo Tirolo, et al.
Rejuvenation Research|July 29, 2011
Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged miceFrancesca L'episcopo, Cataldo Tirolo, Nunzio Testa, et al.
Aging and Disease|September 16, 2021
Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson's DiseaseLoredana Leggio, Greta Paternò, Silvia Vivarelli, et al.
International Journal of Molecular Sciences|December 14, 2017
microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic ApproachesLoredana Leggio, Silvia Vivarelli, Francesca L'Episcopo, et al.
Journal of Pineal Research|February 28, 2006
Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's diseaseGaia Rocchitta, Rossana Migheli, Giovanni Esposito, et al.
Advanced Healthcare Materials|September 1, 2020
Mastering the Tools: Natural versus Artificial Vesicles in NanomedicineLoredana Leggio, Giuseppe Arrabito, Vittorio Ferrara, et al.
Annals of the New York Academy of Sciences|January 22, 2005
Apoptotic cell death and amyloid precursor protein signaling in neuroblastoma SH-SY5Y cellsValentina Venezia, Claudio Russo, Emanuela Repetto, et al.
Pageof 5